What Is a Fixed Perfusion Defect of the Heart’s Inferior Wall?

A fixed perfusion defect of the heart’s inferior wall means that a specific region at the bottom of the heart consistently receives less blood flow than it should, both during stress and at rest. On a nuclear imaging scan, the inferior wall appears darker than surrounding tissue in every phase of the test, suggesting that the muscle there has been permanently damaged, usually by a prior heart attack. But the inferior wall sits right above the diaphragm, and that anatomical quirk makes it the single most common location for imaging artifacts that mimic real damage. Sorting genuine scars from false alarms is one of the trickiest jobs in cardiac imaging.

Where the Inferior Wall Is and Why It Matters

The inferior wall is the underside of the heart’s left ventricle, the chamber responsible for pumping blood to the rest of the body. It rests against the diaphragm, the dome-shaped muscle that drives breathing. Blood reaches this region mainly through the right coronary artery in most people. One anatomical study found the right coronary artery supplied the inferior surface in about 70% of hearts, with the left coronary system taking over in roughly 20% and both sides sharing the job in the remaining 10%.¹ This variation in plumbing, called coronary dominance, directly shapes which artery’s blockage puts the inferior wall at risk.²

Because the right coronary artery is the dominant supplier in the majority of people, a blockage there is the most common cause of an inferior wall heart attack. Research comparing patients who had an acute inferior heart attack with matched controls found that right-dominant anatomy was significantly more common among the heart attack patients, roughly doubling the odds of that event compared to left-dominant anatomy.³ In practical terms, if your cardiologist says you have a fixed perfusion defect on the inferior wall, the right coronary artery is the first suspect.

What “Fixed” Means on a Perfusion Scan

A myocardial perfusion scan typically involves two rounds of imaging. In the first, your heart is stressed, either through exercise on a treadmill or with a drug that mimics exercise. In the second, your heart is at rest. A radioactive tracer is injected into your bloodstream, and a camera captures how evenly the tracer distributes through the heart muscle. Healthy tissue lights up brightly in both phases. If a region looks dim during stress but fills in at rest, that is called a reversible defect, and it usually indicates ischemia: the artery feeding that zone cannot keep up when demand rises, but blood still trickles through when the heart calms down.

A fixed defect behaves differently. The same area looks dim during stress and stays dim at rest. The usual interpretation is that the muscle cells in that zone have died and been replaced by scar tissue, which cannot absorb the tracer regardless of conditions. An inferior wall fixed defect, then, points toward a previous heart attack in that region or, less commonly, another process that has replaced functioning muscle with scar.

The Diaphragm Problem

Here is where the inferior wall becomes uniquely frustrating for imaging specialists. The diaphragm sits directly below the inferior wall and is denser than lung tissue. When the camera’s gamma rays pass through that thick dome of muscle, some get absorbed or scattered before they reach the detector. The result is a dimmer-looking inferior wall that can look identical to a genuine scar. This phenomenon, called diaphragmatic attenuation, is particularly common in men, whose diaphragms tend to sit higher relative to the heart.⁴

Organs below the diaphragm add another layer of interference. Radioactive tracer naturally collects in the stomach, liver, intestines, and gallbladder after injection. When the ratio of tracer activity in those organs to tracer activity in the heart muscle reaches a certain level, the spill-over signal can create a cold spot on the inferior wall or mask a real defect entirely.⁵ These subdiaphragmatic artifacts are common enough that they sometimes force repeat imaging, tying up equipment and extending the patient’s time in the lab.⁶ Scattered radiation from nearby structures can also partially or completely hide perfusion defects that are actually there, meaning the artifact problem cuts both ways: it can fabricate defects and conceal real ones.⁷

Body weight amplifies the issue. Patients with a higher body mass index show more inferior wall attenuation on scans, both visually and when measured with software.⁸ That means a heavier patient who has never had a heart attack can easily end up with a scan that looks like one.

How Cardiologists Tell Artifacts From Real Scars

Because inferior wall artifacts are so common, imaging labs have developed several tricks to separate them from genuine damage. The simplest is prone imaging: after the standard scan taken while you lie on your back, the technologist asks you to flip onto your stomach. Gravity shifts the diaphragm away from the heart, and if the defect disappears in the prone images, it was almost certainly an artifact. In one study of 120 patients who showed an inferior defect while supine, about 78% had a completely normal-looking inferior wall once they were repositioned prone. Coronary angiography confirmed that the vast majority of those patients had a wide-open right coronary artery.⁹

Gated imaging is another powerful tool. By syncing the camera to the heart’s electrical rhythm, technologists can produce a short movie of the heart beating. If the inferior wall in a fixed defect still contracts and thickens normally during each heartbeat, scar tissue is unlikely: dead muscle does not squeeze. One early study found that over 90% of fixed defects showing normal wall motion and thickening could be explained by attenuation artifacts, with breast tissue responsible in women (anterior wall) and the diaphragm in men (inferior wall).¹⁰ Comparing prone and gated approaches head to head, both boosted the specificity of inferior wall disease detection from roughly 50% to over 80%.¹¹

More advanced labs now use hybrid SPECT/CT cameras that generate a CT-based attenuation correction map. The CT scan measures exactly how much tissue the gamma rays must pass through at every angle, and software adjusts the perfusion images accordingly. This approach improved specificity for detecting right coronary artery disease, especially in men.¹² Iterative reconstruction algorithms and CT-based corrections have been shown to work particularly well in obese patients, where the attenuation problem is most severe.⁸

When a Fixed Defect Is Real

Once artifacts have been ruled out, a persistent fixed perfusion defect on the inferior wall strongly suggests that heart muscle in that area has been replaced by scar. The usual culprit is a previous myocardial infarction, sometimes one the patient did not even know they had. Population-based imaging research using cardiac MRI with a contrast agent called gadolinium has shown that unrecognized heart attacks are more common than most people realize, and the inferior and inferolateral segments of the left ventricle are among the most frequently affected zones.¹³ A person can have a small heart attack, attribute the symptoms to indigestion or a pulled muscle, and not discover the scar until a perfusion scan is done years later for an unrelated reason.

In terms of prognosis, a confirmed fixed perfusion defect carries real weight. One large study of patients without previously known coronary artery disease found that those with fixed abnormalities on their stress perfusion scans had a yearly mortality rate of about 4.4%, compared with 2.7% for patients whose defects were reversible. After adjusting for other risk factors, the presence of a fixed perfusion defect was independently associated with roughly two and a half times the risk of death.¹⁴ This makes sense: a fixed defect represents muscle that is already gone, meaning the heart’s pumping ability has taken a permanent hit.

Is the Muscle Always Completely Dead?

Not necessarily, and this is a point that matters enormously for treatment. Some tissue that looks dead on a standard perfusion scan is actually “hibernating.” It has reduced blood flow and has stopped contracting, but the cells are alive and could recover if blood supply were restored. Nuclear medicine labs can test for viability using a glucose-based radiotracer. Living heart cells, even sick ones, consume glucose for energy. Dead scar tissue does not.

In one study of patients with fixed perfusion defects, about 40% showed glucose uptake in the region of the defect, suggesting that at least some of the tissue was still viable.¹⁵ Finding viable tissue changes the conversation. Revascularization, whether through a stent or bypass surgery, has the potential to wake that hibernating muscle back up. If the tissue is truly dead, restoring blood flow to the area will not help it contract again, although it could still benefit surrounding zones that are ischemic.

How Treatment Decisions Hinge on the Scan

Whether a patient with a fixed defect benefits more from medication alone or from a procedure to reopen blocked arteries depends on several overlapping factors. Research examining patients with stable coronary disease found that revascularization offered a clear advantage over medical therapy when the total perfusion defect was large, when there was marked ischemia alongside the fixed defect, or when the heart’s pumping efficiency (ejection fraction) was already reduced below 50%. When defect size was accounted for alongside ejection fraction and ischemia in multivariate analysis, it was the reduced ejection fraction and the extent of ischemia that drove the benefit of revascularization, not the raw size of the defect alone.¹⁶

In plain terms: a large fixed defect on its own does not automatically mean you need a procedure. But if that fixed defect sits alongside active ischemia in other regions or a weakened pump, the case for intervention strengthens considerably. This is why cardiologists look at the entire scan in context, not just the one dark patch on the inferior wall.

Complications Unique to Inferior Wall Damage

The inferior wall has an anatomical relationship with the heart’s electrical wiring that makes damage there behave differently from damage elsewhere. The atrioventricular (AV) node, the relay station that passes electrical signals from the upper chambers to the lower ones, gets its blood supply from a branch of the artery feeding the inferior wall in most people. When an inferior wall heart attack also involves the right ventricle, the risk of serious heart block, where the electrical signal gets delayed or stuck entirely, jumps dramatically. In one study, the rate of high-degree AV block was about 48% in patients with both inferior and right ventricular involvement, compared to 13% in those with inferior wall damage alone.¹⁷ Additional research has confirmed that mortality from heart block is higher when the right ventricle is involved.¹⁸

This does not mean that every person with a fixed inferior defect will develop electrical problems. Many inferior heart attacks are small enough or positioned in a way that spares the AV node’s blood supply. But if you have a documented inferior infarction and experience symptoms like dizziness, fainting, or a very slow pulse, your doctor will likely think about conduction disturbances early in the workup.

Collateral Circulation and Why Some Defects Stay Smaller Than Expected

The heart has a backup system that sometimes limits damage. When a coronary artery narrows slowly over months or years, tiny natural bypasses called collateral vessels can grow from neighboring arteries to feed the starving territory. These collaterals do not fully replace the blocked artery, but they can supply enough blood to keep some muscle alive.

The trade-off is interesting. Research on patients with a single completely blocked coronary artery found that the more developed the collateral network, the more likely it was for the donor artery’s territory to show perfusion defects of its own. In other words, the artery lending blood through collaterals can become stretched thin, developing a mild deficit in its own region in the process.¹⁹ For patients, this means a perfusion scan after a chronic total occlusion of the right coronary artery might show a fixed defect on the inferior wall that is smaller than expected, thanks to collaterals from the left side, but subtle new deficits elsewhere. It is a reminder that the heart’s plumbing is interconnected, and reading a perfusion scan always requires looking at the full picture.

Why the Inferior Wall Is the Artifact Capital of Cardiac Imaging

No other segment of the heart generates as many false-positive findings on nuclear scans. The inferior wall sits in an anatomical bad neighborhood for imaging: below it is the diaphragm, which moves with every breath. Behind and below that sit the liver, stomach, and loops of bowel, all of which absorb the radiotracer and create competing signals. The chest wall above the heart is relatively thin and airy by comparison, so the anterior wall (the front of the heart) in men rarely shows attenuation artifacts. In women, breast tissue creates a parallel artifact problem on the anterior wall, but the physics and the fix are the same: recognize the anatomy, apply prone or gated imaging or attenuation correction, and re-evaluate.

Improvements in reconstruction algorithms have helped. Iterative methods that repeatedly refine the image, rather than computing it in a single pass, reduce artifact severity.²⁰ Newer camera designs with cadmium-zinc-telluride detectors offer better energy resolution, which further cleans up scatter from the gut. And cardiac MRI, which does not rely on gamma-ray detection at all, can confirm or deny an inferior scar using gadolinium contrast without any of the diaphragmatic interference that plagues nuclear scans.

If you have been told you have a fixed perfusion defect on the inferior wall, the first practical question to ask your cardiologist is whether prone imaging, gated analysis, or attenuation correction was used to confirm it. If the defect persists through all those checks, the finding is much more likely to represent true scarring and warrants a deeper conversation about viability testing, medication adjustments, and whether further imaging or angiography is the right next step.